ASX:PCK PainChek (PCK) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About PainChek Stock (ASX:PCK) Get PainChek alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationA$50.62 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Development and commercialisation of mobile medical applications that are intended to provide pain assessment for individuals who are unable to communicate with their carers. Read More Receive PCK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PainChek and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PCK Stock News HeadlinesPainChek Ltd Announces Quotation of New Securities on ASXOctober 14 at 7:09 PM | msn.comThe Bull Case For PainChek (ASX:PCK) Could Change Following Historic FDA Approval and US Market Entry – Learn WhyOctober 10, 2025 | finance.yahoo.comWhy I'm avoiding Nvidia (and buying these 3 AI stocks instead)Everyone's buying Nvidia. The financial media can't stop talking about it. Your neighbor probably owns it. That's exactly why I'm looking elsewhere. See, when everyone piles into the same trade, the easy money is already gone. The real profits come from finding what the crowd is missing.October 15 at 2:00 AM | TradingTips (Ad)Health Check: Smiles all around as PainChek wins FDA seal of approval for its groundbreaking digital appOctober 8, 2025 | msn.comHealth Check: Smiles all around as PainChek wins FDA seal of approval for its groundbreaking digital appOctober 8, 2025 | msn.comJunior health-tech firm's shares race to 12-month high on US regulatory clearanceOctober 8, 2025 | msn.comSurging +175% YTD on no news, PainChek issues halt on Tuesday, flagging FDA update. Is this a leaky ship?October 7, 2025 | msn.comMore pain, more gain: The summit’s in sight for PainChek on the tougher climb to the US marketOctober 2, 2025 | msn.comSee More Headlines Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:PCK CIKN/A Webwww.painchek.com Phone1800 098 809FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$8.31 million Net Margins-310.93% Pretax MarginN/A Return on Equity-653.62% Return on Assets-148.84% Debt Debt-to-Equity RatioN/A Current Ratio1.44 Quick Ratio3.60 Sales & Book Value Annual SalesA$2.67 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.00 per share Price / BookN/AMiscellaneous Outstanding Shares1,640,000,000Free FloatN/AMarket CapA$50.62 million OptionableNot Optionable Beta0.74 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (ASX:PCK) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PainChek Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share PainChek With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
